Spyre Therapeutics, Inc. Common Stock (SYRE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SYRE. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 6,506,605 | $578M | INCREASED |
| State Street | 3,057,416 | $271M | INCREASED |
| Remedium Capital Partners | 1,464,169 | $130M | INCREASED |
| Pictet Asset Management Holding | 628,138 | $56M | INCREASED |
| Emerald Advisers | 567,430 | $50M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Cameron Turtle (Chief Executive Officer) | SELL | 16 | $2K | 2026-08-03 |
| Cameron Turtle (Chief Executive Officer) | SELL | 1,392 | $135K | 2026-08-03 |
| Cameron Turtle (Chief Executive Officer) | SELL | 5,635 | $541K | 2026-08-03 |
| Cameron Turtle (Chief Executive Officer) | SELL | 7,157 | $681K | 2026-08-03 |
| Cameron Turtle (Chief Executive Officer) | SELL | 800 | $75K | 2026-08-03 |
Full institutional holdings, insider history, and congressional trades for Spyre Therapeutics, Inc. Common Stock on SentiSense.